Daniel A. Lemberg

5.0k total citations
124 papers, 3.3k citations indexed

About

Daniel A. Lemberg is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Daniel A. Lemberg has authored 124 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Genetics, 48 papers in Surgery and 34 papers in Epidemiology. Recurrent topics in Daniel A. Lemberg's work include Inflammatory Bowel Disease (57 papers), Microscopic Colitis (29 papers) and Eosinophilic Esophagitis (21 papers). Daniel A. Lemberg is often cited by papers focused on Inflammatory Bowel Disease (57 papers), Microscopic Colitis (29 papers) and Eosinophilic Esophagitis (21 papers). Daniel A. Lemberg collaborates with scholars based in Australia, New Zealand and United States. Daniel A. Lemberg's co-authors include Andrew S. Day, Steven T. Leach, Hazel M. Mitchell, Li Zhang, Nadeem O. Kaakoush, Marc Sidler, Lily Nahidi, Kevan Jacobson, R H Jackson and Si Ming Man and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Daniel A. Lemberg

119 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel A. Lemberg Australia 34 1.6k 1.1k 1.1k 689 450 124 3.3k
Steven T. Leach Australia 36 1.7k 1.1× 1.1k 1.0× 1.2k 1.1× 1.2k 1.7× 510 1.1× 121 3.9k
Jorge Amil Dias Portugal 31 1.5k 0.9× 1.8k 1.6× 1.1k 1.1× 416 0.6× 659 1.5× 114 4.4k
Anders Pærregaard Denmark 31 2.1k 1.4× 1.2k 1.1× 1.5k 1.4× 1.2k 1.7× 632 1.4× 119 4.9k
Bénédicte Pigneur France 18 1.4k 0.9× 828 0.7× 828 0.8× 2.9k 4.2× 1.1k 2.4× 46 4.6k
Séamus Hussey Ireland 23 698 0.4× 393 0.3× 911 0.9× 990 1.4× 271 0.6× 67 2.8k
Ellen Scherl United States 34 2.0k 1.3× 1.1k 0.9× 1.5k 1.4× 1.6k 2.3× 922 2.0× 170 5.1k
Natalia Borruel Spain 25 1.4k 0.9× 637 0.6× 894 0.8× 2.1k 3.0× 772 1.7× 73 3.8k
Valérie Verhasselt Australia 36 399 0.3× 617 0.5× 940 0.9× 1.1k 1.6× 267 0.6× 78 4.9k
S. Strobel United Kingdom 27 540 0.3× 596 0.5× 484 0.5× 548 0.8× 196 0.4× 59 3.6k
Mikael Kuitunen Finland 31 386 0.2× 500 0.4× 478 0.5× 1.2k 1.8× 217 0.5× 70 3.9k

Countries citing papers authored by Daniel A. Lemberg

Since Specialization
Citations

This map shows the geographic impact of Daniel A. Lemberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Lemberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Lemberg more than expected).

Fields of papers citing papers by Daniel A. Lemberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Lemberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Lemberg. The network helps show where Daniel A. Lemberg may publish in the future.

Co-authorship network of co-authors of Daniel A. Lemberg

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Lemberg. A scholar is included among the top collaborators of Daniel A. Lemberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Lemberg. Daniel A. Lemberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmed, Tasnia, Daniel A. Lemberg, Andrew S. Day, & Steven T. Leach. (2025). The Interplay Between Immunological Status and Gut Microbial Dysbiosis in the Development of the Symptoms of Irritable Bowel Syndrome: A Systematic Review with Meta-Analysis. Digestive Diseases and Sciences. 71(2). 376–410. 1 indexed citations
2.
Coffey, Michael J., et al.. (2025). Neuromuscular and vascular hamartoma-like lesion in a 16-year-old girl with Crohn disease. Pathology. 57. S52–S52.
4.
Champion, G. David, et al.. (2021). Familial and Genetic Influences on the Common Pediatric Primary Pain Disorders: A Twin Family Study. Children. 8(2). 89–89. 7 indexed citations
5.
Liu, Jeffrey, Viraj C. Kariyawasam, Thomas J. Borody, et al.. (2021). High prevalence of Crohn disease and ulcerative colitis among older people in Sydney. The Medical Journal of Australia. 214(8). 365–370. 13 indexed citations
6.
Sharma, Ajay, Swathi Eluri, Hamish Philpott, Daniel A. Lemberg, & Evan S. Dellon. (2020). EoE Down Under Is Still EoE: Variability in Provider Practice Patterns in Australia and New Zealand Among Pediatric Gastroenterologists. Digestive Diseases and Sciences. 66(7). 2301–2310. 3 indexed citations
7.
Prichard, David O., Zachary Hamilton, Thomas Savage, et al.. (2019). Capsule Endoscopy Complements Magnetic Resonance Enterography and Endoscopy in Evaluating Small Bowel Crohn’s Disease. Journal of the Canadian Association of Gastroenterology. 8 indexed citations
9.
Lopez, Robert, et al.. (2017). Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease. Mediators of Inflammation. 2017. 1–9. 12 indexed citations
10.
Kaakoush, Nadeem O., Donald S. Thomas, David Lynch, et al.. (2016). Campylobacter concisus utilizes blood but not short chain fatty acids despite showing associations with Firmicutes taxa. Microbiology. 162(8). 1388–1397. 3 indexed citations
11.
Kaakoush, Nadeem O., Andrew S. Day, Steven T. Leach, et al.. (2015). Effect of Exclusive Enteral Nutrition on the Microbiota of Children With Newly Diagnosed Crohn's Disease. Clinical and Translational Gastroenterology. 6(1). e71–e71. 88 indexed citations
12.
Leach, Steven T., et al.. (2015). Current roles of specific bacteria in the pathogenesis of inflammatory bowel disease. AIMS Microbiology. 1(1). 82–91. 5 indexed citations
13.
Lemberg, Daniel A. & Andrew S. Day. (2014). Crohn disease and ulcerative colitis in children: An update for 2014. Journal of Paediatrics and Child Health. 51(3). 266–270. 32 indexed citations
14.
Wright, Emily K., James S. Williams, Jane M. Andrews, et al.. (2014). Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease. Internal Medicine Journal. 44(5). 490–496. 48 indexed citations
15.
Ledder, Oren, Daniel A. Lemberg, Chee Y. Ooi, & Andrew S. Day. (2013). Are Thiopurines Always Contraindicated After Thiopurine‐Induced Pancreatitis in Inflammatory Bowel Disease?. Journal of Pediatric Gastroenterology and Nutrition. 57(5). 583–586. 24 indexed citations
16.
Nahidi, Lily, Steven T. Leach, Daniel A. Lemberg, & Andrew S. Day. (2013). Osteoprotegerin Exerts Its Pro-inflammatory Effects Through Nuclear Factor-κB Activation. Digestive Diseases and Sciences. 58(11). 3144–3155. 23 indexed citations
17.
Leach, Steven T., et al.. (2010). Development and Assessment of a Modified Pediatric Crohn Disease Activity Index. Journal of Pediatric Gastroenterology and Nutrition. 51(2). 232–236. 23 indexed citations
18.
Lemberg, Daniel A., et al.. (2007). Inflammatory Bowel Disease in the South Asian Pediatric Population of British Columbia. The American Journal of Gastroenterology. 102(5). 1077–1083. 125 indexed citations
19.
Pinsk, Vered, Daniel A. Lemberg, Collin Barker, et al.. (2005). PEDIATRIC INFLAMMATORY BOWEL DISEASE: THE BRITISH COLUMBIA EXPERIENCE. Journal of Pediatric Gastroenterology and Nutrition. 41(4). 545–545. 2 indexed citations
20.
Lemberg, Daniel A., et al.. (2002). Tolerabilities of Antiretrovirals in Paediatric HIV Infection. Drug Safety. 25(14). 973–991. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026